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Abstract
The molecular mechanisms whereby calcium stimulates secretion are uncertain. In the present study, we used streptolysin
 .  .O SLO -permeabilized chief cells from guinea pig stomach to investigate whether protein phosphatase-2B calcineurin , a
calciumrcalmodulin-dependent, serinerthreonine phosphatase plays a role in mediating calcium-induced pepsinogen
secretion. Preincubation of cells with a-naphthylphosphate, a non-specific phosphatase inhibitor, decreased calcium-induced
 .secretion. Likewise, specific inhibitors of protein phosphatase-2B cyclosporin-A and FK-506 caused a dose-dependent
reduction in calcium-induced pepsinogen secretion. Moreover, in intact cells, cyclosporin-A and FK-506 inhibited
pepsinogen secretion caused by cholecystokinin, carbamylcholine and A23187, agonists known to increase chief cell
cytosolic calcium. Okadaic acid, an inhibitor of protein phosphatase-1 and -2A, had no effect on secretion caused by these
agonists. Chief cell calcium-dependent phosphatase activity, measured using radiolabeled casein as substrate, was reduced
selectively by inhibitors of protein phosphatase-2B. Endogenous substrates for calciumrcalmodulin-dependent phosphatase
activity were identified by analyzing chief cell lysates using 2-dimensional gel electrophoresis. Increasing the cytosolic
calcium concentration resulted in dephosphorylation of a 55-kDa, acidic cytoskeletal protein. FK-506 inhibited dephospho-
rylation of this protein. Thus, in permeabilized chief cells, specific inhibitors of protein phosphatase-2B inhibit calcium-in-
duced pepsinogen secretion, calciumrcalmodulin-dependent phosphatase activity and calcium-induced dephosphorylation of
 .a 55-kDa, acidic cytoskeletal protein. These results support the hypothesis that protein phosphatase-2B calcineurin plays
an important role in mediating calcium-induced exocytosis. q 1997 Elsevier Science B.V.
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1. Introduction
Evidence in many secretory tissues indicates that
increases in cellular calcium concentration trigger
Abbreviations: PP, protein phosphatase; CsA, cyclosporin A;
NS, naphthylsulfate; NP, naphthylphosphate; PMSF, phenyl-
methylsulfonylfluoride; DTT, dithiothreitol.
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exocytosis. Recent advances, such as the SNARE
w xhypothesis 1,2 , suggest that calcium and other sec-
ond messengers interact with a group of proteins that
constitute the cellular machinery for the discharge of
secretory storage vesicles. However, the mechanisms
whereby calcium interacts with these proteins re-
w xmains uncertain 1,2 . Amongst other effects, eleva-
tions in cytosolic calcium lead to activation of protein
kinases and phosphatases. Although the role of ki-
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nases in mediating calcium-induced signal transduc-
w xtion has been studied in some detail 3–6 , less is
known regarding the role of protein phosphatases.
It has been suggested that protein phosphatase-2B
 .PP-2B , also known as calcineurin, which is one of
the four major types of serinerthreonine phos-
phatases found in a variety of tissues, plays a role in
w xstimulus-secretion coupling 7–12 . Groblewski et al.
w x13 demonstrated that inhibitors of PP-2B inhibit
agonist-induced dephosphorylation of a 24-kDa cy-
tosolic protein that was identified in rat pancreas.
Similarly, one of these inhibitors, cyclosporin A
 .CsA , reduced amylase release that was stimulated
 .by cholecystokinin, carbamylcholine carbachol and
w xthe calcium-mobilizing agent, thapsigargin 13 . These
results suggest that, in rat pancreatic acini, PP-2B
plays a role in mediating the secretory actions of
calcium-mobilizing agents.
In the present study, we used streptolysin O
 .SLO -permeabilized chief cells from guinea pig
stomach to investigate the role of PP-2B in mediating
calcium-induced pepsinogen secretion. These cells
are permeant to small molecules and retain the ability
w xto secrete pepsinogen following stimulation 14,15 .
We report here that, in permeabilized chief cells,
 .cyclosporin-A CsA and FK-506, specific inhibitors
w xof PP-2B 16,17 , inhibit agonist- and calcium-in-
duced pepsinogen secretion, calciumrcalmodulin-de-
pendent phosphatase activity and calcium-induced
dephosphorylation of a 55-kDa acidic cytoskeletal
protein. These results demonstrate that, in gastric
chief cells, PP-2B plays an important role in mediat-
ing calcium-induced exocytosis.
2. Materials and methods
2.1. Materials
 .Male Hartley guinea pigs 150–175 g were ob-
tained from Camm Research Lab Animals, Wayne,
 . NJ, USA; collagenase type I , bovine albumin frac-
.  .  .tion V BSA ; dithiothreitol DTT , 1-naph-
 .  .thylphosphate 1-NP , 1-naphthylsulfate 1-NS , car-
 .bachol, phenylmethylsulfonyl fluoride PMSF and
EGTA from Sigma; A23187 from Calbiochem; SLO,
 . basal medium Eagle’s amino acids 100-times con-
. centrated and essential vitamin solution 100-times
.concentrated from Grand Island Biological, Grand
Island, NY, USA; Percoll from Pharmacia LKB
Biotechnology Inc.; 125I-albumin from ICN;
w 32 x 32g P ATP and P-orthophosphate from DuPont-
New England Nuclear; calmodulin from Upstate
 .Biotechnology Inc. Lake Placid, NY, USA ; chole-
 .  . cystokinin- 26–33 CCK from Peninsula Labs. Be-
.lmont, CA, USA ; and calmidazolium from Janssen
 .Life Science Products Belgium . CN-412 was kindly
provided by Dr Claude Klee, National Cancer Insti-
 .tute Bethesda, MD, USA . CsA, FK-506 and CGS-
9343B were kindly provided by Sandoz Pharmaceuti-
 . cals NJ , Fujisawa Pharmaceutical Corp. Osaka
. Japan and Ciba-Geigy Pharmaceuticals Basel,
.Switzerland , respectively.
2.2. Tissue preparation and determination of
pepsinogen secretion
Dispersed chief cells from guinea pig stomach
were prepared as described previously by collagenase
digestion of gastric mucosa, cell dispersal in a cal-
cium-free solution containing EGTA, and fractiona-
tion of chief cells on a Percoll density gradient
w x14,18 . The composition of the cell suspension was
determined daily by light microscopy using morpho-
w x w xlogical criteria 18 . As in previous studies 14,18 ,
chief cells constituted at least 85% of the total cell
population and trypan blue exclusion was greater
than 95%. The cells were washed and resuspended
three times in permeabilization solution consisting of
120 mM KCl, 30 mM NaCl, 1 mM MgCl , 1 mM2
 .K HPO , 10 mM PIPES pH 7.0 , 1 mM ATP and 12 4
 .mgrml bovine serum albumin BSA . Isolated chief
cells were preincubated alone or with inhibitors for
 .30 min. SLO 30 IUrml and calcium were added
simultaneously. Free calcium concentration was ad-
w xjusted using an EGTA-CaCl buffering system 19 .2
Pepsinogen secretion and peptic activity were deter-
mined using 125I-albumin substrate as described pre-
viously and expressed as the percentage of total
cellular pepsinogen that was released into the medium
w xduring the incubation 20 . The assay was linear over
a range that was at least twofold that of the maximal
value assayed.
2.3. Measurement of phosphatase acti˝ity
Prior to 32P labeling, casein was dephosphorylated
w xby heating at 1008C for 10 min at pH 9.5 21 . The
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solution was allowed to cool and the pH adjusted to
6.0. Phosphorylation of casein was carried out at
308C in a 1-ml reaction mixture containing 50 mM
 .MES pH 6.0 , 1250 Sigma unitsrml catalytic sub-
unit of cAMP-dependent kinase, 10 mM MgCl , 3002
mCi 32P-ATP and 10 mg dephosphorylated casein.
w x22 . This mixture was incubated for 40 min and
passed through a Sephadex G-50 column 1.5=85
.  .cm equilibrated with 50 mM MES pH 6.5 to
separate radiolabeled casein from 32P-ATP. Fractions
containing phosphorylated casein were stored at 48C
and used within 10 days of preparation, during which
time TCA-precipitable radioactivity remained )
96%. The specific activity of 32P-casein was approxi-
mately 60 000 cpmrmg protein.
Isolated chief cells were preincubated at 378C,
alone or with 0.1 mM FK-506 or 1 mM okadaic acid,
for 30 min. The cells were centrifuged and resus-
pended in hypotonic lysis solution 50 mM b-
w xglycerophosphate pH 7.0 , 0.4 mM EGTA, 10 mgrml
leupeptin, 1 mM PMSF, 10 mgrml aprotinin and 0.5
.mM DTT . After freezing and thawing the cell sus-
 .pension 3 times, cell lysate 10 ml was incubated in
w a total of 60 ml reaction mixture 30 mM PIPES pH
.7.0 , 0.4 mM EGTA, 1 mM PMSF, 10 mgrml
xleupeptin and 0.1 mM DTT at 308C for 10 min. The
32  .reaction was initiated by adding P-casein 10 ml
and the samples were incubated at 308C for 3 min.
The reaction was stopped by adding 100 ml of 1%
 .  .BSA wrv and 100 ml 25% wrv trichloroacetic
acid, and placing the samples on ice for 5 min. The
tubes were vortexed and centrifuged 12 000=g for
.3 min . Fifty microliters of supernatant were removed
and radioactivity was measured by liquid scintillation
counting to determine 32P released by phosphatase
activity in the lysate. Under these conditions, sponta-
32  .neous hydrolysis of P-casein in the blank no lysate
was not detectable.
2.4. Labeling of chief cell phosphoproteins and 2-di-
mensional gel electrophoresis
Chief cell phosphoproteins were labeled by incu-
 7 . 32bating cells 10 cellsrml in the presence of P-or-
 .thophosphate 1 mCirml at 378C for 90 min. During
the last 30 min of incubation, the cell suspension was
divided into 2 aliquots and incubated in the absence
or presence of 0.1 mM FK-506. The samples were
washed 3 times with permeabilization solution
 .without BSA and added to tubes containing SLO
and 0.1 or 1 mM calcium in the absence or presence
of 0.1 mM FK-506 and incubated for 3 min at 378C.
Chief cell proteins were solubilized and subjected to
2-dimensional polyacrylamide gel electrophoresis as
w xdescribed previously 15 .
Autoradiographic spot intensity was measured us-
ing the Phosphorimager System Molecular Dynam-
.ics, CA . Dried gels were exposed to the phophor
screen and scanned on the Phosphorimager SF scan-
ner. Spots on the scans were circumscribed and their
integrated volume obtained using ImageQuant soft-
ware on a Gateway 2000 computer. To account for
gel to gel variability, p55 phosphorylation intensity
was normalized relative to three reference phospho-
proteins present on all autoradiographs. The intensity
of these reference proteins was not altered by in-
creased calcium concentration.
2.5. Chief cell fractionation
Chief cell phosphoproteins were labeled with 32P
 7 .as described above and cells approx. 5=10 cells
were suspended in homogenization solution 50 mM
w xb-glycerophosphate pH 7.0 , 10 mgrml leupeptin,
10 mgrml aprotinin, 0.3 mM PMSF and 1 mM
.EGTA and freeze-thawed 3 times. A 200-ml sample
was taken to identify phosphoproteins in the lysate. A
 .500-ml sample was centrifuged 100 000=g for 40
min and 200 ml of the supernatant was taken to
identify phosphoproteins in the cytosol. The pellet
was resuspended in 500 ml homogenization solution
containing 1% Triton X-100 and placed on ice for 30
min. Triton-treated fractions were centrifuged
 . 100 000=g for 40 min and the supernatant 200
.ml was taken to identify phosphoproteins in mem-
brane fractions. Finally, the pellet was resuspended in
500 ml homogenization solution and 200 ml was
taken to identify phosphoproteins in the cytoskeleton.
Two-dimensional polyacrylamide gel electrophoresis
was performed as described above.
3. Results and discussion
To determine the general role of protein phos-
phatases in mediating pepsinogen secretion, we ex-
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amined the effect of preincubating chief cells with
 .1-naphthylphosphate 1-NP , a non-specific inhibitor
of protein phosphatases. Whereas 1-naphthylsulfate
 .1-NS did not alter pepsinogen secretion, 1-NP re-
 .duced basal and calcium-induced secretion Fig. 1a .
 .A maximal concentration of 1-NP 10 mM reduced
calcium-induced secretion by 61%. To determine
whether these effects were caused by inhibition of
serinerthreonine phosphatases, we examined the ef-
fects of adding more specific inhibitors. As shown in
Fig. 1b and c, the PP-2B inhibitors, CsA and FK-506,
reduced calcium-induced pepsinogen secretion in a
concentration-dependent manner. Okadaic acid, an
w xinhibitor of PP-1 and PP-2A 23 , did not alter basal
 .or calcium-induced pepsinogen secretion Fig. 1b .
 .Moreover, CN-412 100 mM , a peptide inhibitor of
PP-2B that consists of a 25-amino acid fragment
from the autoinhibitory domain of the phosphatase
w x  .24 , decreased calcium 1 mM -induced pepsinogen
 .secretion by 28% data not shown . Because PP-2B is
a calciumrcalmodulin-dependent enzyme, we exam-
ined the actions of two calmodulin inhibitors, calmi-
 .Fig. 1. Effect of phosphatase and calmodulin inhibitors on calcium-induced pepsinogen secretion from permeabilized chief cells. a Chief
 .  .  .  .  .cells were preincubated with no additions v , 10 mM 1-naphthylsulfate 1-NS B or 10 mM 1-naphthylphosphate 1-NP ’ , and
 .  .  .then permeabilized as described in Section 2. b Chief cells were preincubated with no additions v , 1 mM okadaic acid ’ , 0.1 mM
 .  .  .  .CsA % or 0.1 mM FK-506 B , and then permeabilized. c Chief cells were preincubated with increasing concentrations of CsA B
 . 2qor FK-506 v , and then permeabilized. Values on ordinate represent pepsinogen secretion at indicated Ca concentration in the
 .  . w  .absence of inhibitors. d Chief cells were preincubated with no additions v or calmodulin inhibitors 0.1 mM calmidazolium B or
 .x100 mM CGS 9343B ’ , and then permeabilized. In each experiment, the ordinate represents the percentage of total cellular
pepsinogen at the start of the experiment that was released during the incubation. Values were determined in duplicate and represent
means from 4 separate experiments. Bars, S.E.M.
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w xdazolium and CGS-9343B 4,25 . Calmidazolium and
CGS-9343B reduced calcium-stimulated secretion by
 .50 and 67%, respectively Fig. 1d .
Table 1 shows the actions of FK-506 on pepsino-
gen secretion stimulated by maximal concentrations
of carbachol, CCK and A23187; agonists that in-
w xcrease chief cell cytosolic calcium 20 , and phorbol
 .12-myristate 13-acetate PMA , an agent that acti-
vates protein kinase C. For these experiments we
used cells that had not been permeabilized with SLO.
Preincubation with FK-506 alone did not alter basal
pepsinogen secretion, but reduced agonist-induced
 .pepsinogen secretion by 30–40% Table 1 . Similar
results were obtained using cyclosporin as a PP-2B
 .inhibitor data not shown . As suggested by Grob-
w xlewski et al. 13 , the probable reason that PP-2B
inhibitors reduce agonist-induced secretion to a lesser
extent than calcium-induced secretion is that the ago-
nists stimulate multiple cellular signalling pathways,
including activation of protein kinase C. The com-
plexity of these interactions is demonstrated by the
observation that PMA-induced pepsinogen secretion
is also reduced by the addition of FK-506. Neverthe-
less, these results indicate that PP-2B is specifically
involved in mediating pepsinogen secretion that is
stimulated by agents that activate the phospholipase
C signalling system. It is difficult to separate the
actions of the calciumrcalmodulin and PKC limbs of
the phospholipase C signalling pathway. For exam-
ple, a PKC substrate, MARCKS for Myristoylated
.Alanine-Rich C Kinase Substrate , is thought to act
as a calmodulinrcalmodulin buffer that, depending
on its level of phosphorylation, modulates the activity
of calciumrcalmodulin-dependent enzymes, like PP-
w x2B 26,27 . In chief cells, experimental evidence
indicates that PMA-induced phosphorylation of a
MARCKS-like protein releases calmodulin which is
then free to interact with enzymes, like PP-2B, thereby
w xstimulating pepsinogen secretion 28 . Hence, it is not
surprising that PP-2B inhibitors reduce PMA-induced
pepsinogen secretion.
In contrast to the results shown in Table 1, the
PP-2B inhibitors did not alter cholera toxin-induced
 .pepsinogen secretion data not shown , which is me-
diated by activation of adenylyl cyclase and an in-
w xcrease in cellular cAMP 29 .
To measure phosphatase activity directly in chief
cells, we examined the ability of cell lysates to
Table 1
Effect of a PP-2B inhibitor on agonist-induced pepsinogen secre-
tion from non-permeabilized chief cells
 .Agonist Pepsinogen secretion % total
Alone qFK-506
None 1.5"0.3 1.6"0.3
aCCK, 3 nM 5.8"0.8 4.5"0.8
aCarbachol, 10 mM 7.2"0.6 5.5"0.7
aA23187, 100 nM 7.5"0.7 5.8"0.6
aPMA, 100 nM 7.9"0.7 6.1"0.8
Dispersed chief cells from guinea pig stomach were preincubated
with no additions or 100 nM FK-506 at 378C. After 30 min, the
indicated concentrations of the agonists were added and the
incubation continued for an additional 15 min. Pepsinogen secre-
tion was calculated as the percentage of pepsinogen in cells at the
beginning of incubation that was released into the extracellular
medium during the course of the 45-min incubation. Each value
represents the mean"S.E.M. from 4 separate experiments.
a Value significantly less than that obtained in the absence of
 .inhibitor P -0.05, paired t-test .
32  .dephosphorylate P-labeled casein Fig. 2 .
Calcium-independent phosphatase activity no added
.calcium or calmodulin, 0.4 mM EGTA was inhibited
41% by okadaic acid, but was not altered by FK-506
 .Fig. 2a . Adding 1 mM calcium and 1 mM calmod-
ulin increased protein phosphatase activity by approx.
 .100% Fig. 2a . Calcium-dependent phosphatase ac-
tivity was calculated by subtracting calcium-indepen-
dent activity from phosphatase activity measured in
the presence of calcium and calmodulin. Preincuba-
 .tion of cells with okadaic acid 1 mM or FK-506
 .0.1 mM decreased phosphatase activity measured in
 .the presence of calcium and calmodulin Fig. 2a .
Whereas okadaic acid inhibited calciumrcalmodu-
lin-independent phosphatase activity, FK-506 inhib-
ited phosphatase activity only in the presence of
 .calcium and calmodulin Fig. 2a . The actions of
 .FK-506 were concentration-dependent Fig. 2b . The
maximal concentration of FK-506, 0.1 mM, inhibited
calciumrcalmodulin-dependent phosphatase activity
 .by 63% Fig. 2b . These results provide further evi-
dence for PP-2B-like phosphatase activity in gastric
chief cells.
To identify endogenous substrates for PP-2B in
chief cells, cellular proteins were labeled with 32P-or-
thophosphate and the cells were permeabilized in the
 w x.presence of 0.1 mM basal calcium 20 or 1 mM
calcium. Phosphoproteins were separated by 2-di-
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 .Fig. 2. Effects of phosphatase inhibitors on chief cell phosphatase activity. a Effect of 1 mM calcium, 1 mM calmodulin and protein
 . )phosphatase inhibitors 1 mM okadaic acid, 0.1 mM FK-506 on protein phosphatase activity in chief cell lysates. P-0.02 compared to
phosphatase activity in the presence of 0.4 mM EGTA. )) P-0.05 compared to phosphatase activity measured in the presence of
 .calcium and calmodulin alone. b Dose-response effect of FK-506 on calcium-dependent protein phosphatase activity in chief cell
lysates. ) ,) ) P-0.05 and 0.01, respectively, compared to control. Values were determined in duplicate and represent means from 4
separate experiments. Bars, S.E.M.
mensional gel electrophoresis and visualized by auto-
radiography. As shown in Fig. 3a and b, the addition
of calcium resulted in a 34% decrease in the intensity
 .of a 55-kDa acidic pI, approx. 5.5 phosphoprotein.
Upon dephosphorylation, the 55-kDa phosphoprotein
appears as 2 to 3 closely adjacent spots. We believe
that this represents varying phosphorylation of the
same protein. Dephosphorylation of proteins fre-
quently results in a ‘basic shift’ on 2-dimensional
gels. Preincubation of chief cells with 0.1 mM FK-506
inhibited calcium-induced dephosphorylation of this
 .55-kDa protein Fig. 3d .
To determine the subcellular location of the 55-kDa
protein, we prepared cytosolic, membrane and cyto-
skeletal fractions of 32P-orthophosphate-labeled chief
cell lysates and separated the proteins in these frac-
tions by 2-dimensional gel electrophoresis. Compari-
son of autoradiographs from the lysate and the vari-
ous fractions indicate association of this phosphopro-
 .tein with the cytoskeleton Fig. 4d .
Few studies have shown a relation between cal-
ciumrcalmodulin-dependent phosphatase activity and
exocytosis. In Paramecium, microinjection of a cal-
ciumrcalmodulinrPP-2B complex triggers exocyto-
w xsis and dephosphorylation of a 65-kDa protein 12 .
Moreover, in these cells, exocytosis is inhibited by
injection of anti-PP-2B antibodies. In rat pancreatic
acini, okadaic acid concentrations )1 mM inhibit
calcium-dependent amylase secretion and protein de-
w xphosphorylation 11 . It should be noted that these
concentrations of okadaic acid inhibit PP-2B in addi-
w xtion to PP-1 and PP-2A 30 . Similar results have
w xbeen reported using parotid acini 31 . Moreover, in
secretory granules prepared from rat parotid acini,
calcium-dependent dephosphorylation of a 36-kDa
w xprotein has been observed 32 . In contrast to the
observations in pancreatic and parotid acini, and the
present results, the addition of PP-2A or PP-2B to
permeabilized PC12 cells inhibits calcium-dependent
w xnorepinephrine secretion 10 . Nevertheless, in terms
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Fig. 3. Effect of FK-506 on calcium-induced dephosphorylation
of 32P-labeled chief cell proteins. Representative autoradiographs
of 2-dimensional polyacrylamide gels are shown for: a, 0.1 mM
calcium; b, 1 mM calcium; c, 0.1 mM calcium plus 0.1 mM
FK-506; and d, 1 mM calcium plus 0.1 mM FK-506. The pH
gradient and position of molecular weight markers are indicated
on the abscissa and ordinate, respectively. Dashed circles indicate
altered phosphoproteins.
of structure and function, gastric chief cells resemble
pancreatic and parotid acinar cells more closely than
PC12 cells, which are of neuronal origin.
It is of interest to compare the results of the
present study to those reported by Groblewksi et al.
w x13 in rat pancreatic acini. The ability and potency of
CsA to inhibit secretion in rat acini and guinea pig
chief cells appears similar. However, in contrast to
the failure of FK-506 to inhibit agonist-induced amy-
lase release from rat pancreatic acini, in chief cells,
we observed that CsA and FK-506 were approxi-
mately equipotent. This may reflect differing tissue
expression of immunophilins. Immunophilins are en-
dogenous proteins, like cyclophilin or FK-binding
protein, that bind intracellularly to exogenous agents
w xlike cyclosporin and FK-506, respectively 33–35 .
The inhibitory actions of cyclosporin and FK-506 are
dependent on binding to their respective im-
w xmunophilins 33–35 . Moreover, whereas Groblewski
w xet al. 13 identified an endogenous 24-kDa cytosolic
PP-2B substrate, we identified a protein substrate that
is larger and associated with the chief cell cytoskel-
ton.
Whether or not dephosphorylation of the 55-kDa
cytoskeletal protein is involved directly with exocyto-
sis cannot be answered by the present studies.
Nonetheless, the association of this endogenous PP-
2B substrate with the cytoskeleton is intriguing.
Destabilization of cytoskeletal proteins may occur
following dephosphorylation by PP-2B, thereby en-
abling secretory granules to fuse with the plasma
membrane. Several cytoskeletal proteins can be de-
w xphosphorylated by PP-2B 36,37 . Moreover, changes
in the state of phosphorylation of cytoskeletal pro-
teins has been shown to alter cellular morphology
Fig. 4. Localization of putative PP-2B substrate in subcellular
fractions from dispersed chief cells. Representative autoradio-
 .graphs of 2-dimensional polyacrylamide gels are shown for a
 .  .chief cell lysate; b cytosolic fraction; c membrane fraction;
 .and d cytoskeletal fraction. Dashed circles indicate altered
phosphoproteins. The pH gradient and position of molecular
weight markers are indicated on the abscissa and ordinate, respec-
tively.
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w x38,39 . We cannot exclude the possibility that other
chief cell phosphoproteins, that are not detected by
the methods used in the present study, are substrates
for PP-2B and regulate secretion.
In vivo and in vitro studies of pepsinogen secretion
from gastric chief cells indicate that the physiological
actions of cholinergic agonists and the peptide hor-
mone cholecystokinin are mediated in part by in-
w w xxcreases in cytosolic calcium for review see ref. 40 .
Agonist-induced increases in cytosolic calcium may
activate PP-2B. In recent years, it has become appar-
ent that protein phosphatases do more than just mod-
ulate protein kinase activity. Our experiments with
inhibitors of PP-2B and calmodulin in gastric chief
cells indicate that activation of this phosphatase plays
an important role in driving calcium-dependent exo-
cytosis.
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